The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT systems and potentially accelerating its reviews of medical products.Jeremy Walsh was named head of IT and AI, according to his post on LinkedIn. The move was first reported by Politico. Walsh previously held the role of chief technologist at Booz Allen Hamilton, managing AI- and cloud-based projects for 14 years at the consultancy.RelatedHe joins the agency amid a push from ...